Renalytix Income Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Revenue	3	2.3	3.4	2.97	1.49
Revenue Growth (YoY)	30.44%	-32.41%	14.58%	99.19%	-
Cost of Revenue	1.8	2.1	2.68	2.1	0.86
Gross Profit	1.2	0.2	0.72	0.87	0.63
Selling, General & Admin	17.3	23.4	28.66	39.52	23.48
Research & Development	0.9	5.1	14.3	14.65	10.04
Operating Expenses	18.2	30.5	42.96	54.17	33.52
Operating Income	-17	-30.3	-42.24	-53.3	-32.89
Interest Expense	-0.5	-	-	-	-
Interest & Investment Income	-	0.2	0.1	0.01	0.2
Earnings From Equity Investments	-	-	-0.01	0.01	-2.11
Currency Exchange Gain (Loss)	0.3	-0.5	0.36	9.69	-8.77
Other Non Operating Income (Expenses)	-0.1	-	0.36	0.12	1.41
EBT Excluding Unusual Items	-17.3	-30.6	-41.44	-43.46	-42.17
Gain (Loss) on Sale of Investments	-0.6	-0.6	-1.08	-5.9	6.48
Gain (Loss) on Sale of Assets	-	-	-	-	0.05
Asset Writedown	-	-10.5	-	-	-
Other Unusual Items	-3.9	-3.8	-3.09	4.11	0.3
Pretax Income	-21.8	-45.5	-45.61	-45.25	-35.34
Income Tax Expense	-1.4	-	0	0.03	-
Earnings From Continuing Operations	-20.4	-45.5	-45.61	-45.28	-35.34
Minority Interest in Earnings	-	-	-	-	0.61
Net Income	-20.4	-45.5	-45.61	-45.28	-34.73
Net Income to Common	-20.4	-45.5	-45.61	-45.28	-34.73
Shares Outstanding (Basic)	275	108	82	73	71
Shares Outstanding (Diluted)	275	108	82	74	71
Shares Change (YoY)	153.82%	31.59%	11.34%	3.29%	21.00%
EPS (Basic)	-0.07	-0.42	-0.55	-0.62	-0.49
EPS (Diluted)	-0.07	-0.42	-0.55	-0.67	-0.49
Free Cash Flow	-17.9	-29.8	-34.09	-46.48	-29.17
Free Cash Flow Per Share	-0.07	-0.28	-0.41	-0.63	-0.41
Gross Margin	40.00%	8.70%	21.16%	29.43%	42.45%
Operating Margin	-566.67%	-1317.39%	-1241.26%	-1794.55%	-2205.63%
Profit Margin	-680.00%	-1978.26%	-1340.20%	-1524.44%	-2328.97%
Free Cash Flow Margin	-596.67%	-1295.65%	-1001.62%	-1565.02%	-1956.54%
EBITDA	-16.8	-30.1	-41.93	-53.01	-32.69
D&A For EBITDA	0.2	0.2	0.31	0.29	0.2
EBIT	-17	-30.3	-42.24	-53.3	-32.89

Source: S&P Global Market Intelligence. Standard template. Financial Sources.